Biotech Companies Get “IPO fever”

Home/Financial/Biotech Companies Get “IPO fever”

Biotech Companies Get “IPO fever”

San Francisco Business Times reports on local biotechs’ latest IPO moves.

The companies:

Tobira Therapeutics
Tobira is focused on developing and commercializing innovative therapeutics to treat liver disease, human immunodeficiency virus, or HIV-1, fibrosis and inflammation. Its lead product candidate, cenicriviroc, or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. 

Zosano Pharma
Zosano is advancing a pipeline of drug candidates based on the ZP Patch Technology – a proprietary transdermal delivery technology capable of delivering peptides, proteins, small molecules and vaccines by permeating the skin’s outer layer and ensuring significant and rapid therapeutic effect

Intersect ENT is a health care equipment company based in Menlo Park, California. It manufactures drug-delivery devices used by Ear, Nose & Throat clinicians in the treatment of sinusitis


June 25th, 2014|